6th International Young Scientist Congress (IYSC-2020) and Workshop on Intellectual Property Rights. 10th International Science Congress (ISC-2020).  International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

A review on biodegradation of pharmaceuticals through microorganisms

Author Affiliations

  • 1Dept. of Environ. Sci. and Engineering, Indian Institute of Technology (IIT) Indian School of Mines (ISM), Dhanbad - 826004, Jharkhand, India
  • 2Dept. of Environ. Sci. and Engineering, Indian Institute of Technology (IIT) Indian School of Mines (ISM), Dhanbad - 826004, Jharkhand, India
  • 3Dept. of Environ. Sci. and Engineering, Indian Institute of Technology (IIT) Indian School of Mines (ISM), Dhanbad - 826004, Jharkhand, India

Int. Res. J. Environment Sci., Volume 6, Issue (8), Pages 66-72, August,22 (2017)


Pharmaceuticals are one of the most critical evolving contaminants. The highest source of the pharmaceuticals contamination is the hospitals, household and pharmaceuticals manufactures. Numerous methods for example physico-chemical and biological methods have been employed in the degradation of pharmaceuticals. As physico-chemical methods are expensive, biological methods- thorough microorganisms are extensively used. A better understanding of the mechanism of biodegradation has a high ecological significance that depends on the indigenous microorganisms to transform or mineralize the organic contaminants. The present review gives a short discussion on the role of microorganisms in degradation of pharmaceuticals.


  1. Oppenheimer J., Stephenson R., Burbano A. and Liu L. (2007)., Characterizing the Passage of Personal Care Products throughWastewater Treatment Processes., Water Environment Research., 79(13), 2564-2577.
  2. Daughton C.G. and Ternes T.A. (1999)., Pharmaceuticals and personal care products in the environment: agents of subtle change?., Environ Health Persp., 107, 907.
  3. Daughton C.G. (2003)., Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health: I Rationale for and avenues toward a green pharmacy., Environ Health Persp., 111(5), 757-774.
  4. Richardson B.J., Lam P.K. and Martin M. (2005)., Emerging chemicals of concern: pharmaceuticals and personal care products (Pharmaceuticals) in Asia, with particular reference to Southern China., Mar. Pollut. Bull., 50(9), 913-920.
  5. Mompelat S., Le Bot B. and Thomas O. (2009)., Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water., Environ. Int., 35(5), 803-814.
  6. Kaestner M., Nowak K.M., Miltner A., Trapp S. and Schaeffer A. (2014)., Classification and modelling of nonextractable residue (NER) formation of xenobiotics in soil- synthesis., Crit. Rev.Environ. Sci.Technol., 44(19), 2107-2171.
  7. Kallenborn R.K., Berger U. and Järnberg U. (2004)., Perfluorinated Alkylated Substances (pfas) in the Nordic Environment., Nordic Council of Ministers.
  8. Mompelat S., Le Bot B. and Thomas O. (2009)., Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water., Environ. Int., 35(5), 803-814.
  9. Calamari D., Zuccato E., Castiglioni S., Bagnati R. and Fanelli R. (2003)., Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy., Environ. Sci.Technol., 37(7), 1241-1248.
  10. Moldovan Z. (2006)., Occurrences of pharmaceutical and personal care products as micro pollutants in rivers from Romania., Chemosphere., 64(11), 1808-1817.
  11. Kasprzyk-Hordern B., Dinsdale R.M. and Guwy A.J. (2008)., The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK., Water Res., 42(13), 3498-3518.
  12. Huerta-Fontela M., Galceran M.T. and Ventura F. (2011)., Occurrence and removal of pharmaceuticals and hormones through drinking water treatment., Water Res., 45(3), 1432-1442.
  13. Wu M., Xiang J., Que C., Chen F. and Xu G. (2015)., Occurrence and fate of psychiatric pharmaceuticals in the urban water system of Shanghai, China., Chemosphere, 138, 486-493.
  14. Roberts J., Kumar A., Du J., Hepplewhite C., Ellis D.J., Christy A.G. and Beavis S.G. (2016)., Pharmaceuticals and personal care products (PPCPs) in Australia, Sci. Total Environ., 541, 1625-1637.
  15. Cabeza Y., Candela L., Ronen D. and Teijon G. (2012)., Monitoring the occurrence ofemerging contaminants in treated wastewater and groundwater between 2008 and 2010. The Baix Llobregat (Barcelona, Spain)., J. Hazard. Mater., 239, 32-39.
  16. Lopez-Serna R., Jurado A., Vazquez-Sune E., Carrera J., Petrovic M. and Barcelo D. (2013)., Occurrence of 95 pharmaceuticals and transformation products in urban groundwaterr underlying the metropolis of Barcelona, Spain., Environ. Pollut., 174, 305-315.
  17. Karnjanapiboonwong A., Suski J.G., Shah A.A., Cai Q., Morse A.N. and Anderson T.A. (2011)., Occurrence of PPCPs at a wastewater treatment plant and in soil and groundwater at a land application site., Water, Air, & Soil Pollut., 216(1-4), 257-273.
  18. Gottschall N., Topp E., Metcalfe C., Edwards M., Payne M., Kleywegt S., Russell P. and Lapen D. (2012)., Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field., Chemosphere., 87(2), 194-203.
  19. Boyd G.R., Palmeri J.M., Zhang S. and Grimm D.A. (2004)., Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in storm water canals and Bayou St. John in New Orleans, Louisiana, USA., Sci Total Environ., 333, 137-148.
  20. Arslan-Alaton I. and Gurses F. (2004)., Photo-Fenton-like and photo-fenton-like oxidation of Procaine Penicillin G formulation effluent., J. Photochem. Photobiol. A Chem., 165(1), 165-175.
  21. Carballa M., Omil F., Lema J.M., Llompart M.A., García-Jares C., Rodríguez I., Gomez M. and Ternes T. (2004)., Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant., Water Res., 38(12), 2918-2926.
  22. Lindqvist N., Tuhkanen T. and Kronberg L. (2005)., Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters., Water Res., 39(11), 2219-2228.
  23. Narumiya M., Nakada N., Yamashita N. and Tanaka H. (2013)., Phase distribution and removal of pharmaceuticals and personal care products during anaerobic sludge digestion., J. Hazard. Mater., 260, 305-312.
  24. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D. and Zuccato E. (2006)., Removal of pharmaceuticals in sewage treatment plants in Italy., Environ Sci Technol., 40, 357-363.
  25. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., Lee Bill, Servos Mark, Beland Michel and Seto Peter (2006)., Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada., Sci Total Environ., 367, 544-558.
  26. Paxeus N. (2004)., Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment., Water Sci Technol., 50(5), 253-260.
  27. Santos J.L., Aparicio I. and Alonso E. (2007)., Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain)., Environ Int., 33(4), 596-601.
  28. Glassmeyer Susan T., Hinchey Elizabeth K., Boehme Susan E., Daughton Christian G., Ruhoy Ilene S., Conerly Octavia, Daniels Rebecca L., Lauer Lisa, McCarthy Meg., Nettesheim Todd G., Sykes Kathy and Thompson Virginia G. (2009)., Disposal practices for unwanted residential medications in the United States., Environment international, 35(3), 566-572.
  29. Santosa I.J., Grossmana M.J., Sartorattob A., Ponezib A.N. and Durranta L.R. (2012)., Degradation of the recalcitrant pharmaceuticals carbamazepine and 17a-ethinylestradiol by ligninolytic fungi., Chem. Eng., 27, 169-174.
  30. Popa C., Favier L., Dinica R., Semrany S., Djelal H., Amrane A. and Bahrim G. (2014)., Potential of newly isolated wild Streptomyces strains as agents for the biodegradation of a recalcitrant pharmaceutical, carbamazepine., Environ. Technol., 35(24), 3082-3091.
  31. Jiang B., Li A., Cui D., Cai R., Ma F. and Wang Y. (2014)., Biodegradation and metabolic pathway of sulfamethoxazole by Pseudomonas psychrophila HA-4, a newly isolated cold-adapted sulfamethoxazole-degrading bacterium., Appl. Microbiol. Biotechnol., 98(10), 4671-4681.
  32. Reis P.J., Reis A.C., Ricken B., Kolvenbach B.A., Manaia C.M., Corvini P.F. and Nunes O.C. (2014)., Biodegradation of sulfamethoxazole and other sulfonamides by Achromobacter denitrificans PR1., J. Hazard. Mater., 280, 741-749.
  33. Liu Y.K. and Wang J.L. (2013)., Degradation of sulfamethazine by gamma irradiation in the presence of hydrogen peroxide., J. Hazard. Mater., 250, 99-105.
  34. Murdoch R.W. and Hay A.G. (2005)., Formation of catechols via removal of acid side chains from ibuprofen and related aromatic acids., Appl. Environ. Microbiol., 71 (10), 6121-6125.
  35. Almeida, B., Kjeldal, H., Lolas, I., Knudsen, A.D., Carvalho, G., Nielsen, K.L.,Crespo, M.B., Stensballe, A., Nielsen, J.L., (2013). Quantitative proteomic analysis of ibuprofen-degrading Patulibacter sp. strain I11. Biodegradation., 24 (5), 615-630., undefined, undefined
  36. De Gusseme B., Vanhaecke L., Verstraete W., Boon N. (2011)., Degradation of acetaminophen by Delftia tsuruhatensis and Pseudomonas aeruginosa in a membrane bioreactor., Water Res., 45(4), 1829-1837.
  37. Zhang L., Hu J., Zhu R., Zhou Q. and Chen J. (2013)., Degradation of paracetamol by pure bacterial cultures and their microbial consortium., Appl. Microbiol. Biotechnol., 97(8), 3687-3698.
  38. Hata T., Kawai S., Okamura H. and Nishida T. (2010)., Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation., Biodegradation., 21(5), 681-689.
  39. Roh H., Subramanya N., Zhao F., Yu C.P., Sandt J., Chu K.H. (2009)., Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteria., Chemosphere., 77 (8), 1084-1089.
  40. Zhou N.A., Lutovsky A.C., Andaker G.L., Ferguson J.F. and Gough H.L. (2014)., Kinetics modeling predicts bioaugmentation with Sphingomonad cultures as a viable technology for enhanced pharmaceutical and personal care products removal during wastewater treatment., Bioresour. Technol., 166, 158-167.
  41. Yang Y. and Chu K.H. (2003)., Kinetics of estrogen degradation by a 17b-estradioldegrading culture, novosphingobium tardaugens ari-1., Proc. Water Environ. Fed., 9, 659-667.
  42. Yoshimoto T., Nagai F., Fujimoto J., Watanabe K., Mizukoshi H., Makino T., Kimura K., Saino H., Sawada H. and Omura H. (2004)., Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates from activated sludge in wastewater treatment plants., Appl. Environ. Microbiol., 70(9), 5283-5289.
  43. Li Z., Nandakumar R., Madayiputhiya N. and Li X. (2012)., Proteomic analysis of 17bestradiol degradation by Stenotrophomonas maltophilia., Environ. Sci. Technol., 46 (11), 5947-5955.
  44. Wang C., Li J., Zhao B., Wang Y. and Liu G. (2014)., Isolation and characteristics of 17 [beta]-estradiol-degrading Dyella spp. strains from activated sludge., Nat. Environ. Pollut. Technol., 13(2), 437.
  45. Roh H., and Chu K.-H. (2011)., Effects of solids retention time on the performance of bioreactors bio augmented with a 17b-estradiol-utilizing bacterium, Sphingomonas strain KC8., Chemosphere., 84(2), 227-233.
  46. Amorim C.L., Moreira I.S., Maia A.S., Tiritan M.E. and Castro P.M. (2014)., Biodegradation of ofloxacin, norfloxacin, and ciprofloxacin as single and mixed substrates by Labrys portucalensis F11., Appl. Microbiol. Biotechnol., 98 (7), 3181-3190.
  47. Ma X., Zhang C., Deng J., Song Y., Li Q., Guo Y. and Li C. (2015)., Simultaneous degradation of estrone, 17b-estradiol and 17a-ethinyl estradiol in an aqueous UV/H2O2 system., Int. J. Environ. Res. Public Health, 12(10), 12016-12029.
  48. Ma Y., Wang L., Liu L. and Zhang X. (2015)., Biodegradation of tylosin residue in pharmaceutical solid waste by a novel Citrobacter amalonaticus strain., Environ. Prog. Sustain. Energy., 34(1), 99-104.
  49. Rodríguez-Rodríguez C.E., García-Galian M.J., Blianquez P., Díaz-Cruz M.S., Barcelio D., Caminal G. and Vicent T. (2012)., Continuous degradation of a mixture of sulfonamides by Trametes versicolor and identification of metabolites from sulfapyridine and sulfathiazole., J. Hazard. Mater., 213, 347-354.
  50. Lin B., Lyu J., Lyu X.-j, Yu H.-q, Hu Z., Lam J.C. and Lam P.K. (2015)., Characterization of cefalexin degradation capabilities of two Pseudomonas strains isolated from activated sludge., J. Hazard. Mater., 282, 158-164.
  51. Gbewonyo K., Buckland B. and Lilly M. (1991)., Development of a large-scale continuous substrate feed process for the biotransformation of simvastatin by Nocardia sp., Biotechnol. Bioeng., 37(11), 1101-1107.
  52. Hu J., Zhang L.L., Chen J.M. and Liu Y. (2013)., Degradation of paracetamol by Pseudomonas aeruginosa strain HJ1012., J. Environ. Sci. Health, Part A., 48(7), 791-799.
  53. Marco-Urrea E., Pierez-Trujillo M., Blianquez P., Vicent T. and Caminal G. (2010)., Biodegradation of the analgesic naproxen by Trametes versicolor and identification of intermediates using HPLC-DAD-MS and NMR., Bioresour. Technol., 101(7), 2159-2166.
  54. Gauthier H., Yargeau V. and Cooper D.G. (2010)., Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism., Sci. Total Environ., 408(7), 1701-1706.
  55. Rodarte-Morales A., Feijoo G., Moreira M. and Lema J. (2011)., Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi., World J. Microbiol. Biotechnol., 27(8), 1839-1846.
  56. Khunjar W., Mackintosh S., Skotnicka-Pitak J., Baik S., Aga D. and Love N. (2011)., Elucidating the relative roles of ammonia oxidizing and heterotrophic bacteria during the biotransformation of 17a-ethinylestradiol and trimethoprim., Environ.Sci. Technol., 45(8), 3605-3612.
  57. Vasiliadou I.A., Molina R., Martínez F. and Melero J.A. (2013)., Biological removal of pharmaceutical and personal care products by a mixed microbial culture: sorption, desorption and biodegradation., Biochem. Eng. J., 81, 108-119.
  58. Grossberger A., Harder Y., Borch T. and Chefetz B. (2014)., Biodegradability of pharmaceutical compounds in agricultural soils irrigated with treated wastewater., Environmental Pollution., 185, 168-177.